These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26337173)

  • 41. Statin-related myotoxicity.
    Fernandes V; Santos MJ; Pérez A
    Endocrinol Nutr; 2016 May; 63(5):239-49. PubMed ID: 27005745
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Help me--I do not tolerate my statin].
    Nater H; Perger L; Suter PM
    Praxis (Bern 1994); 2015 May; 104(10):491-7; quiz 498-9. PubMed ID: 26098050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Rhabdomyolysis following cerivastatin monotherapy--implications for therapy with HMG-CoA reductase inhibitors].
    Sparing R; Sellhaus B; Noth J; Block F
    Nervenarzt; 2003 Feb; 74(2):167-71. PubMed ID: 12596018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of xanthine oxidase to prevent statin-induced myalgia and rhabdomiolysis.
    Alis R; Sanchis-Gomar F; Risso-Ballester J; Perez-Quilis C; Cortell-Ballester J; Romagnoli M; Blesa JR; Emanuele E
    Atherosclerosis; 2015 Mar; 239(1):38-42. PubMed ID: 25568951
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Muscle soreness and rhabdomyolysis.
    Paulsen G; Benestad HB
    Tidsskr Nor Laegeforen; 2019 Jun; 139(10):. PubMed ID: 31238673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and laboratory phenotype of patients experiencing statin intolerance attributable to myalgia.
    Harris LJ; Thapa R; Brown M; Pabbathi S; Childress RD; Heimberg M; Braden R; Elam MB
    J Clin Lipidol; 2011; 5(4):299-307. PubMed ID: 21784376
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myotonic potentials in statin-induced rhabdomyolysis.
    de Almeida DF; Lissa TV; Melo AC
    Arq Neuropsiquiatr; 2008 Dec; 66(4):891-3. PubMed ID: 19099134
    [No Abstract]   [Full Text] [Related]  

  • 48. [Intense physical exercise, muscle involvement and statin use].
    Toussirot E; Michel F; Meneveau N
    Presse Med; 2014 Jun; 43(6 Pt 1):726-7. PubMed ID: 24630267
    [No Abstract]   [Full Text] [Related]  

  • 49. [Rhabdomyolysis related to statin and seizures: report of 3 cases].
    Guan YQ; Shi YJ; Wang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1795-6. PubMed ID: 22027795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical perspectives of statin-induced rhabdomyolysis.
    Antons KA; Williams CD; Baker SK; Phillips PS
    Am J Med; 2006 May; 119(5):400-9. PubMed ID: 16651050
    [TBL] [Abstract][Full Text] [Related]  

  • 51. STATIN-ASSOCIATED INTOLERANCE AND ITS PREVENTION.
    Karsanidze A; Antelava N; Gorgasledze N; Ghonghadze M; Okudzhava M; Pachkoria K
    Georgian Med News; 2018 Jun; (279):155-161. PubMed ID: 30035739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metformin's impact on statin-associated muscle symptoms: An analysis of ACCORD study data and research materials from the NHLBI Biologic Specimen and Data Repository Information Coordinating Center.
    Carris NW; Tsalatsanis A; Tipparaju SM; Cheng F; Magness RR; Kumar A
    Diabetes Obes Metab; 2018 Aug; 20(8):1994-1999. PubMed ID: 29577553
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of aspartate aminotransferase in statin-induced rhabdomyolysis.
    Ruan XC; Low LL; Kwan YH
    J Prim Health Care; 2017 Dec; 9(4):316-320. PubMed ID: 29530144
    [TBL] [Abstract][Full Text] [Related]  

  • 54. STOMPing forward: statins, muscle complaints and CK.
    Laaksonen R
    Atherosclerosis; 2013 Oct; 230(2):256-7. PubMed ID: 24075753
    [No Abstract]   [Full Text] [Related]  

  • 55. Muscle toxicity with statins.
    Hedenmalm K; Alvan G; Ohagen P; Dahl ML
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):223-31. PubMed ID: 20014178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statin administration activates system xC
    Rebalka IA; Cao AW; May LL; Tarnopolsky MA; Hawke TJ
    Am J Physiol Cell Physiol; 2019 Nov; 317(5):C894-C899. PubMed ID: 31509447
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rhabdomyolysis and HMG-CoA reductase inhibitors.
    Omar MA; Wilson JP; Cox TS
    Ann Pharmacother; 2001 Sep; 35(9):1096-107. PubMed ID: 11573861
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in muscle strength in individuals with statin-induced myopathy: A summary of 3 investigations.
    Panza GA; Taylor BA; Dada MR; Thompson PD
    J Clin Lipidol; 2015; 9(3):351-6. PubMed ID: 26073393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myopathy associated with statin therapy.
    Hilton-Jones D
    Neuromuscul Disord; 2008 Jan; 18(1):97-8. PubMed ID: 17892936
    [No Abstract]   [Full Text] [Related]  

  • 60. Development and validation of algorithms for the detection of statin myopathy signals from electronic medical records.
    Chan SL; Tham MY; Tan SH; Loke C; Foo B; Fan Y; Ang PS; Brunham LR; Sung C
    Clin Pharmacol Ther; 2017 May; 101(5):667-674. PubMed ID: 27706800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.